Navigation Links
Sinovac Reports Unaudited First Quarter 2012 Financial Results
Date:5/15/2012

g income (loss)(8,180,522)(3,528,196)Interest and financing expenses (214,320)(69,697)Interest income597,671.00145,374.00Loss on disposal of equipment-(7,704)Other income (expenses)118,078105,969Income (loss)  before income taxes and non-controlling interests(7,679,093)(3,354,254)Income tax recovery (expenses) 2,902(310,422)Consolidated net loss(7,676,191)(3,664,676)Less:  loss attributable to non-controlling interests2,063,136869,720Net loss attributable to stockholders$(5,613,055)$(2,794,956)Net loss$

(7,676,191)

$

(3,664,676)Other comprehensive income Foreign currency translation adjustment646,783839,567Total comprehensive loss(7,029,408)(2,825,109)Less: comprehensive loss attributable to non-controlling interests 1,979,589728,475Comprehensive loss attributable to stockholders$

(5,049,819)

$

(2,096,634)Loss per share
- basic$

(0.10)

$

(0.05)- diluted$

(0.10)

$

(0.05)Weighted average number of shares of common stock outstanding - Basic 54,608,91954,444,077- Diluted54,608,91954,444,077 

 

 

SINOVAC BIOTECH LTD.Incorporated in Antigua and BarbudaConsolidated Statements of Cash FlowsThree months ended March 31, 2012 and 2011(Expressed in U.S. Dollars)Three months endedMarch 3120122011Cash flows used in operating activities  Net income (loss)

$

(7,676,191)

$

(3,664,676) 

  Adjustments to reconcile net income to net cash

   provided by operating activities: - deferred income taxes(2,902)310,422 - stock-based compensation80,17532,662 - inventory provision85,864- - Provision for (recovery of)  doubtful accounts-- - write-down of equipment and loss on disposal-7,704  - unrealized foreign exchange gain(210,581)- - research and development expenditures qualified for&
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results
2. Sinovac to Host Conference Call to Report Fourth Quarter 2011 Unaudited Financial Results
3. Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement
4. Sinovac to Present at 23rd Annual Piper Jaffray Health Care Conference and HK/China Mini Conference 2011 (Healthcare)
5. /C O R R E C T I O N -- Sinovac Biotech Ltd./
6. Sinovac Reports Unaudited Third Quarter 2011 Financial Results
7. Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease
8. Sinovac to Host Conference Call to Report Third Quarter 2011 Unaudited Financial Results
9. Sinovac Reports Unaudited Second Quarter 2011 Financial Results
10. Sinovac Announces Management Changes
11. Sinovac Holds 2011 Annual Shareholders Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... MOUNTAIN VIEW, Calif., March 5, 2015  IRIDEX Corporation (Nasdaq: ... fourth quarter and year ended January 3, 2015.  ... 2014, a record for the Company and up 11% from ... were $42.8 million, also a record, up 12% from $38.3 ... fourth quarter was 50.1%, up from 48.6% in the fourth ...
(Date:3/5/2015)... Bayer HealthCare announced today that it has ... of the American Society of Clinical Oncology (ASCO) to ... designed to unlock vast quantities of information about the ... "Bayer is proud to join ASCO and the Conquer ... to help people whose lives have been affected by ...
(Date:3/5/2015)... , March 5, 2015   AMC ... management solutions recognized for improving the effectiveness and ... that Robert Anazagasty and Jared ... serve as Vice President, Strategic Client Development, and ... These additions support AMC Health,s commitment to accelerating ...
Breaking Medicine Technology:IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 3
... Particle Sciences Inc. (PSI), a leading pharmaceutical ... supplier of ethylene vinyl acetate (EVA) into pharmaceutical ... of drug-eluting devices.  Building on years of collaboration, ... working to provide Particle Sciences with preferred access ...
... IRIDEX Corporation (NASDAQ: IRIX ) today announced that it ... closes on Thursday, May 5, 2011.  In ... with the investment community at 5:00 p.m. Eastern Time ... to discuss the results of the quarter and other business developments. ...
Cached Medicine Technology:Particle Sciences and Celanese EVA Performance Polymers Collaborate to Accelerate Drug-Eluting Device Combinations 2Particle Sciences and Celanese EVA Performance Polymers Collaborate to Accelerate Drug-Eluting Device Combinations 3
(Date:3/5/2015)... A Bakersfield, Calif. state court jury returned a verdict ... plaintiff Coleen M. Perry a total of $5.7 million for ... mesh sling device, manufactured by Ethicon, Inc., a subsidiary of ... at Wagstaff & Cartmell in Kansas City, Mo., ... Rich Freese and Tim Goss of Freese & Goss ...
(Date:3/5/2015)... March 05, 2015 Central Nebraska Imaging ... practice including the brand’s new logo and optimized website. ... the practice’s modern approach to expert diagnostic imaging, centered ... and be built to be a resource for Nebraska ... With automated forms, communication and referral functionality, video content ...
(Date:3/5/2015)... CA (PRWEB) March 05, 2015 On ... titled “Butt Augmentation, Labiaplasty on the Rise, Plastic Surgeons ... by the American Society for Aesthetic Plastic Surgery ... . Both groups reported a year-over-year doubling of surgical ... the physicians quoted in the article, this increase can ...
(Date:3/5/2015)... At the 7th Annual Mississippi ... addiction treatment met today in Jackson, Mississippi to listen ... Among the numerous respected speakers will be William ... role that pain medications have had in today’s opiate ... , "It is hard to believe that much of ...
(Date:3/5/2015)... March 05, 2015 University of ... founded in 1904, has launched a new center ... lifestyle changes. The Northwest Center for Lifestyle and ... support community outreach, and conduct research in the ... diet and nutrition. The center will target efforts ...
Breaking Medicine News(10 mins):Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2
... Prostatitis is a common,problem, yet the antibiotics physicians ... associated with this condition work in only a ... condition have a form called,chronic nonbacterial prostatitis, which ... edition of Harvard Medical School,s Perspectives on Prostate,Disease ...
... psychiatric nurses believe that people with Borderline Personality Disorder (BPD) ... adults suffer from the condition, according to the October issue ... Ninety-eight per cent of nurses said service shortages played a ... disagreements between staff on how to care for people with ...
... York, NYHealth insurance reform plans that build on a ... are shared among government, employers, and enrollees would have ... and would be the most practical to implement according ... Fund Commission on a High Performance Health System. Commissioners ...
... ... By Dana Ullman, MPH Foreword by Dr. Peter Fisher ... There is a good reason that 11,American presidents, 7 popes, Charles Darwin, ... for,homeopathic treatment: homeopathy works! The majority of people in Western society ...
... PHOENIX, Oct. 17, 2007 Two Arizona-based philanthropic ... innovative initiative to develop personalized molecular diagnostics. The ... every persons unique physiological makeup is critical to ... the same time reducing medical costs. , ...
... Onco-genomic guided trial design may increase probability of tumor response ... and ... Inc.,(CTI) (Nasdaq and MTAX: CTIC) and Systems Medicine, LLC (SM), ... first,patient to its complete phase Ib trial of brostallicin used ...
Cached Medicine News:Health News:Antibiotics May Not Help Men's Chronic Pelvic Pain: Harvard Doctors Discuss Alternatives 2Health News:Services for patients with BPD need to be improved say psychiatric nurses 2Health News:Services for patients with BPD need to be improved say psychiatric nurses 3Health News:New report: private/public insurance mix is most practical way to achieve universal coverage 2Health News:New report: private/public insurance mix is most practical way to achieve universal coverage 3Health News:New report: private/public insurance mix is most practical way to achieve universal coverage 4Health News:The Homeopathic Revolution 2Health News:The Homeopathic Revolution 3Health News:Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative 2Health News:Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative 3Health News:Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative 4Health News:U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors 2Health News:U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors 3Health News:U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors 4
... Eyes enzymatic cleaner is a ... removes stubborn deposits in as ... eyes enzymatic cleaner contains an ... irritating film on soft contact ...
... These specialty Eraser instruments have been ... with the right tool for situations ... a series of 25 gauge intraocular, ... discrete treatment of target tissues for ...
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
Titanium. Straight shafts with curved lower tip. Upper tip fits into positioning hole while lower jaw stabilizes the lens. Flat smooth handle with dull finish. Most popular size or model....
Medicine Products: